Varco Leg Care, a New Delhi-based startup, has announced the launch of its new flagship product - ‘Ulsr Soothe Max’ – curated dedicatedly for treatment and cure of foot ulcer.

Formulated with Varco’s Phyto Transdermal Technology™, the product stands out as a first-of-its-kind, revolutionary solution globally, with the potential to enable complete healing and recovery of individuals from foot ulcers (including varicose veins ulcer and diabetic foot ulcer) and related concerns such as foot blisters, calluses and corns, et al.

Of late, both in India and across other parts of the world, infections attributed to diabetic foot ulcer (DFU) are increasingly becoming one of the major causes for hospitalization amongst diabetics. Studies have shown that roughly one in four diabetes patients have the likelihood of developing foot ulcer during their lifetime.

Ulsr Soothe Max – an FDA-approved, made-in-India topical cream, that represents a blend of nature’s healing touch and advanced scientific innovation, is Varco Leg Care’s attempt to mitigate the growing public health burden caused by foot ulcer, while simultaneously redefining existing foot ulcer treatment methodologies and processes worldwide. Depending on the stage of the ulcer, the product, when used regularly, is able to produce optimal positive results for a foot ulcer patient roughly between 4 to 16 weeks’ time period.

As a ‘digital-first’ consumer healthcare brand, post the product launch, they will initially focus on garnering traction for the newly-introduced topical ulcer treatment product through various online channels.